- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clarity Pharmaceuticals Ltd (CU6)
Clarity Pharmaceuticals Ltd stock price live, this page displays ASX CU6 stock exchange data. View the CU6 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Clarity Pharmaceuticals Ltd real time stock price chart below.
What Is the Clarity Pharmaceuticals Ltd Stock Price Today?
The Clarity Pharmaceuticals Ltd stock price today is 2.280.
What Is the Stock Symbol for Clarity Pharmaceuticals Ltd?
The stock symbol for Clarity Pharmaceuticals Ltd is "CU6."
What Stock Exchange Does Clarity Pharmaceuticals Ltd Trade On?
Clarity Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Clarity Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Clarity Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CU6 quote. (ISIN: AU0000165375)
What Is the Clarity Pharmaceuticals Ltd Stock Price Today?
The Clarity Pharmaceuticals Ltd stock price today is 2.280.
What Is the Stock Symbol for Clarity Pharmaceuticals Ltd?
The stock symbol for Clarity Pharmaceuticals Ltd is "CU6."
What Stock Exchange Does Clarity Pharmaceuticals Ltd Trade On?
Clarity Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Clarity Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Clarity Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CU6 quote. (ISIN: AU0000165375)
2.280
+0.010(+0.44%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.265
2.340
52 wk Range
1.800
5.870
CU6 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.2652.340
52 wk Range
1.8005.870
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CU6 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.203
Upside
+215.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.203
(+215.90% Upside)
Earnings
Latest Release
Aug 27, 2026
EPS / Forecast
-0.14 / 27.10
Revenue / Forecast
4.72M / 31M
Compare CU6 to Peers and Sector
Metrics to compare | CU6 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCU6PeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.9x | −5.2x | −0.4x | |
PEG Ratio | 0.18 | −0.11 | 0.00 | |
Price/Book | 4.6x | 3.8x | 2.6x | |
Price / LTM Sales | 80.8x | 8.0x | 3.0x | |
Upside (Analyst Target) | 224.6% | 49.9% | 48.7% | |
Fair Value Upside | Unlock | 22.5% | 7.0% | Unlock |
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceutical products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Clarity Pharmaceuticals (CU6) Stock Price Today?
The Clarity Pharmaceuticals stock price today is 2.280 AUD.
What Stock Exchange Does Clarity Pharmaceuticals Trade On?
Clarity Pharmaceuticals is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Clarity Pharmaceuticals?
The stock symbol for Clarity Pharmaceuticals is "CU6."
What Is the Clarity Pharmaceuticals Market Cap?
As of today, Clarity Pharmaceuticals market cap is 850.630M AUD.
What Is Clarity Pharmaceuticals's Earnings Per Share (TTM)?
The Clarity Pharmaceuticals EPS (TTM) is -0.291.
From a Technical Analysis Perspective, Is CU6 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Clarity Pharmaceuticals Stock Split?
Clarity Pharmaceuticals has split 0 times.
How Many Employees Does Clarity Pharmaceuticals Have?
Clarity Pharmaceuticals has 100 employees.
What is the current trading status of Clarity Pharmaceuticals (CU6)?
As of Sep 05, 2026, Clarity Pharmaceuticals (CU6) is trading at a price of 2.280 AUD, with a previous close of 2.270 AUD. The stock has fluctuated within a day range of 2.265 AUD to 2.340 AUD, while its 52-week range spans from 1.800 AUD to 5.870 AUD.
What Is Clarity Pharmaceuticals (CU6) Price Target According to Analysts?
The average 12-month price target for Clarity Pharmaceuticals is 7.203 AUD, with a high estimate of 8.41 AUD and a low estimate of 5.6 AUD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +215.90% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.